BSE Live
Mar 19, 16:01Prev. Close
4822.85
Open Price
4750.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 19, 15:48Prev. Close
4818.00
Open Price
4784.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4724.50 (10)
| Balance Sheet of Pfizer (in Rs. Cr.) | Nov 09 | Nov 08 | Nov 07 | Nov 06 | Nov 05 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 29.84 | 29.84 | 29.84 | 29.84 | 29.84 | |
| Total Share Capital | 29.84 | 29.84 | 29.84 | 29.84 | 29.84 | |
| Reserves and Surplus | 964.49 | 869.72 | 618.80 | 409.91 | 346.72 | |
| Total Reserves and Surplus | 964.49 | 869.72 | 618.80 | 409.91 | 346.72 | |
| Total Shareholders Funds | 994.33 | 899.56 | 648.64 | 439.76 | 376.57 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 3.87 | 3.01 | 4.50 | 2.26 | 5.15 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 3.87 | 3.01 | 4.50 | 2.26 | 5.15 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 116.25 | 107.27 | 91.73 | 136.67 | 117.16 | |
| Other Current Liabilities | 16.65 | 14.87 | 14.55 | 8.14 | 16.88 | |
| Short Term Provisions | 76.14 | 804.46 | 114.97 | 64.60 | 67.80 | |
| Total Current Liabilities | 209.04 | 926.61 | 221.25 | 209.41 | 201.84 | |
| Total Capital And Liabilities | 1,207.24 | 1,829.18 | 874.40 | 651.43 | 583.55 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 92.33 | 50.61 | 60.01 | 69.80 | 75.41 | |
| Intangible Assets | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | |
| Capital Work-In-Progress | 0.80 | 32.30 | 10.24 | 1.60 | 2.14 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 93.28 | 83.06 | 70.41 | 71.56 | 77.70 | |
| Non-Current Investments | 0.50 | 3.82 | 3.82 | 3.32 | 3.32 | |
| Deferred Tax Assets [Net] | 31.37 | 25.68 | 17.48 | 16.62 | 14.18 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 2.93 | 13.34 | 36.70 | |
| Total Non-Current Assets | 125.16 | 112.56 | 94.64 | 104.83 | 131.90 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 113.37 | 124.68 | 95.06 | 98.45 | 89.83 | |
| Trade Receivables | 64.39 | 59.73 | 61.37 | 69.63 | 82.82 | |
| Cash And Cash Equivalents | 527.40 | 543.06 | 479.79 | 306.51 | 209.93 | |
| Short Term Loans And Advances | 376.42 | 988.66 | 143.04 | 72.01 | 69.07 | |
| OtherCurrentAssets | 0.50 | 0.50 | 0.50 | 0.00 | 0.00 | |
| Total Current Assets | 1,082.08 | 1,716.62 | 779.76 | 546.60 | 451.65 | |
| Total Assets | 1,207.24 | 1,829.18 | 874.40 | 651.43 | 583.55 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 97.12 | 88.33 | 124.25 | 78.64 | 54.30 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 74.57 | 110.17 | 34.72 | 41.88 | 36.03 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.04 | 0.31 | 0.12 | 1.93 | 1.38 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 8.29 | 8.36 | 10.22 | 7.40 | 7.58 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | 15.38 | 33.83 | 27.68 | 12.30 | 12.30 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 3.49 | 1.42 | 0.46 | 1.48 | 2.19 | |
| Other Earnings | 22.10 | 21.56 | 21.61 | 27.06 | 24.78 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.50 | -- | 0.50 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
10.02.2026
Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011
19.03.2026
19.03.2026
18.03.2026
18.03.2026
MFs boost healthcare exposure, turn overweight on earnings recovery and valuations
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth